Evidence map›Paper›PMID 27147658›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.

Leonid P Shutov, Charles A Warwick, Xiaoyu Shi, Aswini Gnanasekaran, Andrew J Shepherd, Durga P Mohapatra, Trent M Woodruff, J David Clark, Yuriy M Usachev

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mitochondrial CaCell calcium · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Leonid P ShutovDepartment of Pharmacology, University of Iowa, Iowa City, Iowa 52242.ORCID 0000-0003-0102-965X
Charles A WarwickDepartment of Pharmacology, University of Iowa, Iowa City, Iowa 52242.ORCID 0000-0001-6244-9821
Xiaoyu ShiDepartment of Anesthesia, Veterans Administration Palo Alto Healthcare System and Stanford University, Palo Alto, California 94305.
Aswini GnanasekaranDepartment of Pharmacology, University of Iowa, Iowa City, Iowa 52242.
Andrew J ShepherdDepartment of Pharmacology, University of Iowa, Iowa City, Iowa 52242, Department of Anesthesiology, Washington University Pain Center, Washington University School of Medicine, St. Louis, Missouri 63110, and.
Durga P MohapatraDepartment of Pharmacology, University of Iowa, Iowa City, Iowa 52242, Department of Anesthesiology, Washington University Pain Center, Washington University School of Medicine, St. Louis, Missouri 63110, and.
Trent M WoodruffSchool of Biomedical Sciences, University of Queensland, St. Lucia, Queensland 4072, Australia.ORCID 0000-0003-1382-911X
J David ClarkDepartment of Anesthesia, Veterans Administration Palo Alto Healthcare System and Stanford University, Palo Alto, California 94305.
Yuriy M UsachevDepartment of Pharmacology, University of Iowa, Iowa City, Iowa 52242, yuriy-usachev@uiowa.edu.
University of Iowa · USVA Palo Alto Health Care System · USThe University of Queensland · AU

Funding

Interdisciplinary Training Program in Pain ResearchT32NS045549 · NINDS · UNIVERSITY OF IOWA · PI KATHLEEN A SLUKA, Yuriy M Usachev · 2004 to 2026
$3.7M
Predoctoral Training in the Pharmacological SciencesT32GM067795 · NIGMS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2004 to 2021
$3.4M
Chemokines, TRP Channels and Cancer PainR01NS069898 · NINDS · WASHINGTON UNIVERSITY · PI MOHAPATRA, DURGA PRASANNA · 2011 to 2015
$1.6M
Complement System Modulation of Nociception and Inflammation after IncisionR01GM079126 · NIGMS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI CLARK, DAVID J. · 2008 to 2011
$1.4M
Mitochondria fission and fusion (MFF)-dependent mechanisms in neuronal toxicityR01NS087068 · NINDS · UNIVERSITY OF IOWA · PI USACHEV, YURIY M · 2014 to 2017
$1.3M
Regulation of TRPV1 and Nociceptor Sensitization by the Complement SystemR01NS072432 · NINDS · UNIVERSITY OF IOWA · PI USACHEV, YURIY M · 2011 to 2014
$1.3M
The Role of Ca-dependent Transcription Factor NFAT in Pain ControlR21NS092851 · NINDS · UNIVERSITY OF IOWA · PI USACHEV, YURIY M · 2015 to 2016
$417k
NIGMS NIH HHS R01 GM079126NIGMS NIH HHS T32 GM067795NINDS NIH HHS R01 NS069898NINDS NIH HHS R01 NS072432NINDS NIH HHS R01 NS087068NINDS NIH HHS R21 NS092851NINDS NIH HHS T32 NS045549
6 · The paper itself

Abstract

unlabelledThe complement cascade is a principal component of innate immunity. Recent studies have underscored the importance of C5a and other components of the complement system in inflammatory and neuropathic pain, although the underlying mechanisms are largely unknown. In particular, it is unclear how the complement system communicates with nociceptors and which ion channels and receptors are involved. Here we demonstrate that inflammatory thermal and mechanical hyperalgesia induced by complete Freund's adjuvant was accompanied by C5a upregulation and was markedly reduced by C5a receptor (C5aR1) knock-out or treatment with the C5aR1 antagonist PMX53. Direct administration of C5a into the mouse hindpaw produced strong thermal hyperalgesia, an effect that was absent in TRPV1 knock-out mice, and was blocked by the TRPV1 antagonist AMG9810. Immunohistochemistry of mouse plantar skin showed prominent expression of C5aR1 in macrophages. Additionally, C5a evoked strong Ca(2+) mobilization in macrophages. Macrophage depletion in transgenic macrophage Fas-induced apoptosis mice abolished C5a-dependent thermal hyperalgesia. Examination of inflammatory mediators following C5a injection revealed a rapid upregulation of NGF, a mediator known to sensitize TRPV1. Preinjection of an NGF-neutralizing antibody or Trk inhibitor GNF-5837 prevented C5a-induced thermal hyperalgesia. Notably, NGF-induced thermal hyperalgesia was unaffected by macrophage depletion. Collectively, these results suggest that complement fragment C5a induces thermal hyperalgesia by triggering macrophage-dependent signaling that involves mobilization of NGF and NGF-dependent sensitization of TRPV1. Our findings highlight the importance of macrophage-to-neuron signaling in pain processing and identify C5a, NGF, and TRPV1 as key players in this cross-cellular communication. SIGNIFICANCE STATEMENT: This study provides mechanistic insight into how the complement system, a key component of innate immunity, regulates the development of pain hypersensitivity. We demonstrate a crucial role of the C5a receptor, C5aR1, in the development of inflammatory thermal and mechanical sensitization. By focusing on the mechanisms of C5a-induced thermal hyperalgesia, we show that this process requires recruitment of macrophages and initiation of macrophage-to-nociceptor signaling. At the molecular level, we demonstrate that this signaling depends on NGF and is mediated by the heat-sensitive nociceptive channel TRPV1. This deeper understanding of how immune cells and neurons interact to regulate pain processing is expected to facilitate mechanism-based approaches in the development of new analgesics.

Indexed as

MacrophagesNerve Growth FactorNociceptorsSignal TransductionTRPV Cation ChannelsAcrylamidesAnimalsBridged Bicyclo Compounds, HeterocyclicCell CommunicationComplement C5aFemaleHot TemperatureHyperalgesiaInflammationMaleMice3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamideAcrylamidesBridged Bicyclo Compounds, HeterocyclicComplement C5aNerve Growth FactorTRPV1 protein, mouseTRPV Cation ChannelsC5aC5aR1complementmacrophageNGFTRPV1

Identifiers

PMID27147658
PMCPMC4854968
OpenAlexW2347130158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.